Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Total Non-Current Liabilities (2020 - 2025)

Oncology Institute's Total Non-Current Liabilities history spans 6 years, with the latest figure at $167.8 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 0.57% year-over-year to $167.8 million; the TTM value through Dec 2025 reached $167.8 million, down 0.57%, while the annual FY2025 figure was $167.8 million, 0.57% down from the prior year.
  • Total Non-Current Liabilities reached $167.8 million in Q4 2025 per TOI's latest filing, down from $175.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $175.9 million in Q3 2025 to a low of $14.2 million in Q1 2021.
  • Average Total Non-Current Liabilities over 5 years is $122.3 million, with a median of $144.6 million recorded in 2023.
  • Peak YoY movement for Total Non-Current Liabilities: skyrocketed 646.25% in 2022, then dropped 4.74% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $92.4 million in 2021, then skyrocketed by 45.63% to $134.5 million in 2022, then rose by 12.87% to $151.8 million in 2023, then grew by 11.12% to $168.7 million in 2024, then decreased by 0.57% to $167.8 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Total Non-Current Liabilities are $167.8 million (Q4 2025), $175.9 million (Q3 2025), and $168.8 million (Q2 2025).